DJO | Jotup

Orthopedic Braces and Support Devices and Equipment Global Market Report 2021 - ResearchAndMarkets.com

Retrieved on:

Lunedì, Settembre 13, 2021

The "Orthopedic Braces and Support Devices and Equipment Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points:

The "Orthopedic Braces and Support Devices and Equipment Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's offering.
The orthopedic braces and support devices and equipment market consists of sales of orthopedic braces and support devices and equipment and related services.
The orthopedic braces and support devices and equipment market is segmented into lower extremity braces, upper extremity braces and back and hip braces.
Global Orthopedic Braces And Support Devices And Equipment Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
7.2.

DJO® Introduces New EMPOWR Dual Mobility™ Hip System at AAOS

Retrieved on:

Martedì, Agosto 31, 2021

EMPOWR Dual Mobility is the latest addition to the EMPOWR Hip portfolio that provides surgeons a solution to treat a large patient group needing better joint stability.

Key Points:

EMPOWR Dual Mobility is the latest addition to the EMPOWR Hip portfolio that provides surgeons a solution to treat a large patient group needing better joint stability.
View the full release here: https://www.businesswire.com/news/home/20210831005150/en/
EMPOWR Dual Mobility Hip (Photo: Business Wire)
Dual mobility (DM) use is climbing in the United States now estimated to be used in 10% of elective primary hip cases and 22% of revision hip cases1.
EMPOWR Dual Mobility provides surgeons with a modern and comprehensive solution for both primary and revision THA procedures.
EMPOWR Dual Mobility offers the industrys largest assembled head size for a given cup size2, aiding in enhanced joint stability.

Dan Berish Joins Precision Medical Products as New President of Acute Care Division

Retrieved on:

Giovedì, Agosto 19, 2021

Industry, ASC Healthcare, ASC, DVT, Acute care, DJO, Time, Deep vein thrombosis, Multimedia, Patient, Blood vessel, Pharmaceutical industry, Medicine

ROCKLIN, Calif., Aug. 19, 2021 /PRNewswire/ -- PrecisionMedical Products, the largest DVT (Deep Vein Thrombosis) medical device company in the nation, welcomes Dan Berish as its new President of Acute Care.

Key Points:

ROCKLIN, Calif., Aug. 19, 2021 /PRNewswire/ -- PrecisionMedical Products, the largest DVT (Deep Vein Thrombosis) medical device company in the nation, welcomes Dan Berish as its new President of Acute Care.
"Dan Berish's unique skill set is almost unparalleled in our industry," said Precision Medical CEO Jeremy Perkins.
"With his extensive DVT & Vascular background in the Acute Care and hospital setting and his acumen for sales strategy, we believe that Dan will continue to position Precision Medical as the premier hospital-to-home DVT medical device company in the nation."
About Precision Medical Products: Since launching as a self-funded startup in 2010, Precision Medical Products has been helping patients recover from surgery, using its innovative products, programs and DVT prevention offerings.

DJO® Acquires MedShape, Inc.

Retrieved on:

Lunedì, Aprile 26, 2021

Surgery, Health, Medical devices, Physical sciences, Chemistry, Natural sciences, Materials science, Smart materials, XC2, DJO, Intramedullary rod, Nickel titanium, Desis, Forward-looking statement, Niti

We believe our acquisitions of STAR\xc2\xae, Trilliant Surgical\xc2\xae, and now MedShape have created a strong position in the space and will create a rapid growth platform,\xe2\x80\x9d said Brady Shirley, CEO of DJO.

Key Points:

We believe our acquisitions of STAR\xc2\xae, Trilliant Surgical\xc2\xae, and now MedShape have created a strong position in the space and will create a rapid growth platform,\xe2\x80\x9d said Brady Shirley, CEO of DJO.
"Tibiotalocalcaneal arthrodesis utilizing a titanium intramedullary nail with an internal pseudoelastic nitinol compression element: a retrospective case series of 33 patients."
For more information, visit: http://www.medshape.com\nThis press release may contain forward-looking statements, including forward-looking statements within the meaning of the U.S.
DJO disclaims any duty to update the information herein.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210426005092/en/\n'

Health iPASS Announces a Strategic Partnership with DJO®

Retrieved on:

Martedì, Aprile 20, 2021

DJO, Colfax Corporation, IPass, States of the United States, Companies

b'OAKBROOK, Ill., April 20, 2021 /PRNewswire-PRWeb/ --Health iPASS, a leading healthcare payments and patient intake software company, announced today a new strategic partnership with DJO, a leading provider of medical technologies designed to keep people moving.

Key Points:

b'OAKBROOK, Ill., April 20, 2021 /PRNewswire-PRWeb/ --Health iPASS, a leading healthcare payments and patient intake software company, announced today a new strategic partnership with DJO, a leading provider of medical technologies designed to keep people moving.
DJO will be offering the Health iPASS suite as part of its award-winning business software solution for healthcare practices, MotionMD.\nThis partnership addresses inefficiencies that plague the healthcare industry\'s cash collections efforts and patient frustrations surrounding unexpected medical bills.
"\nAbout DJO: DJO, a subsidiary of Colfax Corporation (NYSE: CFX), is a leading developer and distributor of high-quality medical devices that provide proven solutions for musculoskeletal health, joint reconstruction, vascular health, and pain management.
For additional information about DJO, please visit http://www.DJOGlobal.com\nAbout Health iPASS: Health iPASS, a Sphere company, gets your medical practice paid, transforming patient bad debt into guaranteed revenue and decreasing patient A/R in a way that your patients love.

DJO® Acquires Trilliant Surgical

Retrieved on:

Mercoledì, Gennaio 20, 2021

Health, Medical Supplies, Other Health, Medical devices, Orthopedic surgery, Trilliant cut, DJO, Surgery

DJO, LLC (DJO or the Company), a leading global provider of medical technologies to get and keep people moving, today announced the acquisition of Trilliant Surgical, a national provider of foot and ankle orthopedic implants.

Key Points:

DJO, LLC (DJO or the Company), a leading global provider of medical technologies to get and keep people moving, today announced the acquisition of Trilliant Surgical, a national provider of foot and ankle orthopedic implants.
The acquisition of Trilliant Surgicals leading product technologies and clinical efficacy supports DJOs focused expansion into the adjacent high-growth $1 billion US foot and ankle market.
In addition to having a broad product portfolio that covers the full universe of foot recon/fixation procedures, Trilliant Surgical is the only provider of the novel Arsenal Foot Plating System.
As a foot and ankle champion since 2007, we are excited to join the DJO family and expand Trilliant Surgicals positive patient impact globally, said Jon Olson, CEO of Trilliant Surgical.

FTC Approves Final Order Imposing Conditions on Stryker Corp.’s Acquisition of Wright Medical Group N.V.

Retrieved on:

Giovedì, Dicembre 17, 2020

Stryker Corporation, Stryker, Competition law, Ankle replacement, Medical device, DJO, Military vehicles, Medicine, Vehicles

Following a public comment period, the Federal Trade Commission has approved a final ordersettling charges that medical device company Stryker Corp.s proposed $4 billion acquisition of competitor Wright Medical Group N.V. would violate federal antitrust law.

Key Points:

Following a public comment period, the Federal Trade Commission has approved a final ordersettling charges that medical device company Stryker Corp.s proposed $4 billion acquisition of competitor Wright Medical Group N.V. would violate federal antitrust law.
According to the complaint, which wasfirst announced in November 2020,the proposed acquisition would likely result in substantial competitive harm to consumers in the U.S. markets for total ankle replacements and finger joint implants.
Commission staff and the staff of the UK Competition and Markets Authority worked cooperatively to analyze the proposed transaction and potential remedies.
The final order requires Stryker and Wright to divest all assets associated with Strykers total ankle replacements and finger joint implants to DJO Global, allowing it to become an independent, viable, and effective competitor in these markets.

FTC Approves Final Order Imposing Conditions on Stryker Corp.’s Acquisition of Wright Medical Group N.V.

Retrieved on:

Giovedì, Dicembre 17, 2020

Stryker Corporation, Stryker, Competition law, Ankle replacement, Medical device, DJO, Military vehicles, Medicine, Vehicles

Following a public comment period, the Federal Trade Commission has approved a final ordersettling charges that medical device company Stryker Corp.s proposed $4 billion acquisition of competitor Wright Medical Group N.V. would violate federal antitrust law.

Key Points:

Following a public comment period, the Federal Trade Commission has approved a final ordersettling charges that medical device company Stryker Corp.s proposed $4 billion acquisition of competitor Wright Medical Group N.V. would violate federal antitrust law.
According to the complaint, which wasfirst announced in November 2020,the proposed acquisition would likely result in substantial competitive harm to consumers in the U.S. markets for total ankle replacements and finger joint implants.
Commission staff and the staff of the UK Competition and Markets Authority worked cooperatively to analyze the proposed transaction and potential remedies.
The final order requires Stryker and Wright to divest all assets associated with Strykers total ankle replacements and finger joint implants to DJO Global, allowing it to become an independent, viable, and effective competitor in these markets.

DJO® Acquires LiteCure Laser Therapy

Retrieved on:

Venerdì, Dicembre 11, 2020

Health, Communications, Medical devices, Technology, General Health, Hardware, Public relations, Investor relations, Health sciences, Applied sciences, Life sciences, Drug discovery, Health policy, Medicinal chemistry, Therapy, Laser, DJO

The LiteCure portfolio was a natural fit for the DJO Recovery Sciences business, bringing together a joint passion for innovation and clinically proven technology, said Brady Shirley, DJO CEO.

Key Points:

The LiteCure portfolio was a natural fit for the DJO Recovery Sciences business, bringing together a joint passion for innovation and clinically proven technology, said Brady Shirley, DJO CEO.
DJO has long respected LiteCures reputation as the market leader in laser light therapy and identified immediate synergies with its Chattanooga rehabilitation business.
LightForce is the industry leader in medical therapy laser manufacturing and innovation, and continually seeks to move the industry forward through laser science, technology, and solutions.
With DJOs expanded reach and resources, we are excited to increase awareness and adoption of deep tissue laser therapy, added Brian Pryor, Founder and CEO of LiteCure.

Global Electrotherapy System Market to surpass US$ 7,664.7 Million by 2027, Says Coherent Market Insights (CMI)

Retrieved on:

Mercoledì, Ottobre 28, 2020

Managed care, General Health, Health, Medical devices, Medtronic, Zynex, Electrotherapy, DJO, Health care, Health, Companies

According to Coherent Market Insights, the global electrotherapy system market is estimated to be valued at US$ 4,523.0 million in 2020 and is expected to exhibit a CAGR of 7.8% during the forecast period (2020-2027).

Key Points:

According to Coherent Market Insights, the global electrotherapy system market is estimated to be valued at US$ 4,523.0 million in 2020 and is expected to exhibit a CAGR of 7.8% during the forecast period (2020-2027).
Key players are focusing on product approval and launch in order to strengthen their position in the global electrotherapy system market.
Among regions, North America is expected to hold dominant position in the global electrotherapy system market over the forecast period.
Key players operating in the global electrotherapy system market are Medtronic Plc, Zynex Medical Inc., DJO Global, Inc., Nevro Corporation, BTL Industries, Inc., Zealmax Innovations Pvt.